Metraipolis › archive › dc_f59c88efca37

Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety — Europe PMC PMID:41572778

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41572778
DOI
10.2174/011570159x415163251205123550
License (as archived)
solo-consultazione
Archived
2026-11-07T05:40:23.610Z
SHA-256 of the archived text
ae888361b0746b379edad58fb978721462337e7e15a457c57603e9c6c6dbdd11
Stable URL of this page
https://metraipolis.com/documento/dc_f59c88efca37

How to cite

Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety — Europe PMC PMID:41572778 — Europe PMC (en), https://europepmc.org/article/MED/41572778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f59c88efca37 (Metraipolis archive dc_f59c88efca37, sha256 ae888361b0746b379edad58fb978721462337e7e15a457c57603e9c6c6dbdd11)
BibTeX
@misc{dcf59c88efca37,
  title = {Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety — Europe PMC PMID:41572778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41572778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f59c88efca37; sha256 ae888361b0746b379edad58fb978721462337e7e15a457c57603e9c6c6dbdd11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41572778. Agents can read the archived copy with the MCP tool read_document.